Nrf2/HO-1 pathway activation by manganese is associated with reactive oxygen species and ubiquitin-proteasome pathway, not MAPKs signaling - PubMed (original) (raw)

doi: 10.1002/jat.1654. Epub 2011 Mar 7.

Affiliations

PMID: 21384399
DOI: 10.1002/jat.1654

Nrf2/HO-1 pathway activation by manganese is associated with reactive oxygen species and ubiquitin-proteasome pathway, not MAPKs signaling

Huangyuan Li et al. J Appl Toxicol. 2011 Oct.

Abstract

Manganese has been known to induce neurological disorders similar to Parkinson's disease. One of the features of manganese-induced neurotoxicity is oxidative stress. Accumulating data implicate NF-E2-related factor 2 (Nrf2) as a key regulator in the adaptive survival response to oxidative stress. Recent studies suggest that the activation of Nrf2 is induced by manganese in PC12 cells. In the present study, we investigated possible links between reactive oxygen species (ROS), proteasome or mitogen-activated protein kinase (MAPK) signaling and Nrf2/HO-1 activation in manganese-treated PC12 cells. After MnCl(2) treatment, there was an increase in nuclear localization and subsequent binding of Nrf2 to the antioxidant-responsive element (ARE) and upregulation of heme oxygenase-1 (HO-1) protein in PC12 cells. Pretreatment with N-acetyl cysteine, a scavenger of reactive oxygen species, suppressed MnCl(2) -induced Nrf2 activation, increase in Nrf2-ARE binding and subsequent upregulation of HO-1 expression. However, pretreatment with lactacystin, an inhibitor of proteasome activity, enhanced MnCl(2) -induced Nrf2 activation, increase in Nrf2-ARE binding and subsequent upregulation of HO-1 expression. Pretreatment of cells with a pharmacological inhibitor of MAPK (ERK inhibitor PD 98059, P38 inhibitor SB203580 or JNK inhibitor SP600125) did not affect the MnCl(2) -induced Nrf2 activation, increase in Nrf2-ARE binding or subsequent upregulation of HO-1 expression. These results suggest that Nrf2/HO-1 activation by Mn in PC12 cells is associated with ROS and the ubiquitin-proteasome pathway, not MAPK signaling.

PubMed Disclaimer

Cited by

Magnetic Resonance Imaging and Manganism: A Narrative Review and Laboratory Recommendations.
Majewski M, Piwko K, Ordak M, Muszynska E, Nasierowski T, Bujalska-Zadrozny M. Majewski M, et al. J Clin Med. 2024 May 10;13(10):2823. doi: 10.3390/jcm13102823. J Clin Med. 2024. PMID: 38792364 Free PMC article. Review.
Targeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury.
Huang Q, Ren Y, Yuan P, Huang M, Liu G, Shi Y, Jia G, Chen M. Huang Q, et al. J Inflamm Res. 2024 Jul 15;17:4683-4700. doi: 10.2147/JIR.S467882. eCollection 2024. J Inflamm Res. 2024. PMID: 39051049 Free PMC article. Review.
Nrf2 Regulates Oxidative Stress and Its Role in Cerebral Ischemic Stroke.
Wang L, Zhang X, Xiong X, Zhu H, Chen R, Zhang S, Chen G, Jian Z. Wang L, et al. Antioxidants (Basel). 2022 Nov 30;11(12):2377. doi: 10.3390/antiox11122377. Antioxidants (Basel). 2022. PMID: 36552584 Free PMC article. Review.
Effects of low dose radiation on immune cells subsets and cytokines in mice.
Liu X, Liu Z, Wang D, Han Y, Hu S, Xie Y, Liu Y, Zhu M, Guan H, Gu Y, Zhou PK. Liu X, et al. Toxicol Res (Camb). 2020 May 11;9(3):249-262. doi: 10.1093/toxres/tfaa017. eCollection 2020 Jun. Toxicol Res (Camb). 2020. PMID: 32670556 Free PMC article.
Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury.
Xiao CL, Lai HT, Zhou JJ, Liu WY, Zhao M, Zhao K. Xiao CL, et al. Mol Neurobiol. 2025 Feb;62(2):2230-2249. doi: 10.1007/s12035-024-04394-z. Epub 2024 Aug 2. Mol Neurobiol. 2025. PMID: 39093381 Review.

Nrf2/HO-1 pathway activation by manganese is associated with reactive oxygen species and ubiquitin-proteasome pathway, not MAPKs signaling - PubMed (original) (raw)